Pacific Biosciences (PACB -29%) takes a big hit despite narrower Q2 losses and better overall...

|About: Pacific Biosciences of Cali... (PACB)|By:, SA News Editor

Pacific Biosciences (PACB -29%) takes a big hit despite narrower Q2 losses and better overall revenues, due to the fact that most of the quarters gains came from accounting measures, rather than actual profit growth.